DRUG OVERDOSE - A HIDDEN HAZARD OF OBESITY

被引：13

作者：

COX, J

MASOOD, M

PARKER, D

PENN, N

HANCOCK, AK

机构：

来源：

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE | 1987年 / 80卷 / 11期

关键词：

D O I：

10.1177/014107688708001118

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：708 / 709

页数：2

共 10 条

[1]

BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO

[2]

2-M

[3]

BENJAMIN RS, 1973, CLIN PHARMACOL THER, V14, P592

[4]

BRENNER DE, 1984, CANCER, V53, P1042, DOI 10.1002/1097-0142(19840301)53:5<1042::AID-CNCR2820530505>3.0.CO

[5]

2-B

[6] GENTAMICIN THERAPY [J].

DEVINE, BJ .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11) :650-655

[7]

LEE YTN, 1980, CANCER, V45, P2231, DOI 10.1002/1097-0142(19800501)45:9<2231::AID-CNCR2820450902>3.0.CO

[8]

2-3

[9] RISK-FACTORS FOR DOXORUBICIN-INDUCED CONGESTIVE HEART-FAILURE [J].

VONHOFF, DD ;

LAYARD, MW ;

BASA, P ;

DAVIS, HL ;

VONHOFF, AL ;

ROZENCWEIG, M ;

MUGGIA, FM .

ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) :710-717

[10]

[No title captured]

← 1 →